Law360 New York February 23 2015 1259 PM ET Japanese drugmaker Sosei Group Corp said Monday it would pay as much as $400 million for a venturebacked British company with several promising treatments in its pipeline yet another signal the |
Thứ Hai, 23 tháng 2, 2015
Japan's Sosei Keeps Pharma Deals Churning With $400M Buy
